PIPA5117778

AKR1B10 Polyclonal Antibody, Invitrogen™

Manufacturer: Thermo Scientific

Select a Size

Pack Size SKU Availability Price
Each of 1 PIPA5117778-Each-of-1 In Stock ₹ 39,427.00

PIPA5117778 - Each of 1

₹ 39,427.00

In Stock

Quantity

1

Base Price: ₹ 39,427.00

GST (18%): ₹ 7,096.86

Total Price: ₹ 46,523.86

Antigen

AKR1B10

Classification

Polyclonal

Formulation

PBS with 0.03% ProClin 300; pH 7

Gene Accession No.

O60218

Gene Symbols

Akr1b10

Immunogen

E. coli-derived Human AKR1B10 fragment

Quantity

100 μL

Primary or Secondary

Primary

Target Species

Human

Form

Liquid

Applications

Immunoprecipitation, Western Blot

Conjugate

Unconjugated

Gene

Akr1b10

Gene Alias

2310005E10Rik; AKR1B10; AKR1B11; AKR1B12; Akr1b16; aldo-keto reductase family 1 member B10; aldo-keto reductase family 1, member B10; aldo-keto reductase family 1, member B10 (aldose reductase); aldo-keto reductase family 1, member B11 (aldose reductase-like); Aldose reductase-like; aldose reductase-like 1; aldose reductase-like peptide; aldose reductase-related protein; ALDRLn; ARL1; ARL-1; ARP; hARP; HIS; HSI; MGC14103; SI reductase; small intestine reductase

Host Species

Rabbit

Purification Method

Antigen affinity chromatography, Protein A

Regulatory Status

RUO

Gene ID (Entrez)

57016

Content And Storage

-20° C, Avoid Freeze/Thaw Cycles

Isotype

IgG

Related Products

Img

Thermo Scientific

PIPA582718

--

Img

Thermo Scientific

PA549731

--

Img

Thermo Scientific

PIPA530280

--

Img

Thermo Scientific

PIPA531006

--

Img

Thermo Scientific

PIPA575221

--

Img

Thermo Scientific

PIPA558425

--

Img

Thermo Scientific

PIPA530218

--

Img

Thermo Scientific

PIPA565722

--

Description

  • AKR1B10, a 316aa protein, catalyzes efficient reduction ofaliphatic and aromatic aldehydes
  • It the first cytosolic NADP (H)-dependent retinal reductase described in humans and is characterized by the presence of a novel NADP binding motif
  • Due to its ability to convert glucose to sorbitol, AKR1B10 may have a role in development of secondary diabetic complications.It is abundantly expressed in adrenal gland, small intestine and colon, with lower levels in liver, thymus, prostate, testis, and skeletal muscle and its levels are up regulated in certain cancers such as hepatocellular carcinoma.